Abstract
Chickenpox could be a severe disease in immunocompromised patients. Live attenuated vaccine is now available. We conducted a trial in 37 leukemic children with OKA varicella vaccine. Full immunization was observed in all 20 seronegative patients. Few side effects and no generalized vaccinal infection were observed. Further studies are warranted to assess the benefit of vaccination in leukemic patients considering the effectiveness of Varicella Zoster Immuno-Globulins and Aciclovir.
Publication types
-
Clinical Trial
-
Multicenter Study
MeSH terms
-
Adolescent
-
Chickenpox / immunology
-
Chickenpox / prevention & control*
-
Chickenpox Vaccine
-
Child
-
Child, Preschool
-
Herpesvirus 3, Human / immunology*
-
Humans
-
Immunocompromised Host*
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / immunology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*
-
Vaccination*
-
Vaccines, Attenuated / adverse effects
-
Vaccines, Attenuated / immunology
-
Viral Vaccines / adverse effects
-
Viral Vaccines / immunology*
Substances
-
Chickenpox Vaccine
-
Vaccines, Attenuated
-
Viral Vaccines